Oncology Clinical Pharmacist II: Patient Care & Education

Dana-Farber Cancer Institute; Boston (MA); On-site; USD 124,000 - 160,000; Full time

Job summary

Dana-Farber Cancer Institute in Boston seeks a Clinical Services Pharmacist II to provide clinical pharmacy services to oncology outpatients, counsel patients starting antineoplastic therapy, and perform drug-therapy assessments. Collaboration with physicians, nurses, and the pharmacy team is essential to deliver comprehensive patient care.

The role emphasizes medication review, adherence monitoring, and education of patients and caregivers, with leadership in clinical protocol development and

Qualifications

• Pharmacists must hold a PharmD or BS in Pharmacy from an accredited college.
• Board certification in the specialty within 18 months.
• Licensed to practice in Massachusetts (or eligible).

Responsibilities

• Practices as a pharmacist following policies and standards.
• Reviews medication orders for appropriateness and completeness.
• Provides clinical consultations and evidence-based treatment recommendations.
• Collaborates with multidisciplinary team during rounds and meetings.
• Educates patients and caregivers on oncology therapies and adherence.
• Documents care activities in the EHR and communicates changes.
• Participates in educational activities and quality improvement.
• Contributes to formulary processes, policy development, and program initiatives.
• Develops teaching materials and monitoring tools to improve care.

Skills

Communication skills

Team collaboration

Drug information

Critical thinking

EHR documentation

Education

Pharmacy degree (PharmD)

Job description

Dana-Farber Cancer Institute in Boston seeks a Clinical Services Pharmacist II to provide clinical pharmacy services to oncology outpatients, counsel patients starting antineoplastic therapy, and perform drug-therapy assessments. Collaboration with physicians, nurses, and the pharmacy team is essential to deliver comprehensive patient care.

The role emphasizes medication review, adherence monitoring, and education of patients and caregivers, with leadership in clinical protocol development and